SARS-CoV-2 infection and persistence in the human body and brain at autopsy.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
12 2022
Historique:
received: 03 12 2021
accepted: 08 11 2022
pubmed: 15 12 2022
medline: 24 12 2022
entrez: 14 12 2022
Statut: ppublish

Résumé

Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction

Identifiants

pubmed: 36517603
doi: 10.1038/s41586-022-05542-y
pii: 10.1038/s41586-022-05542-y
pmc: PMC9749650
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

758-763

Subventions

Organisme : BLRD VA
ID : I01 BX005469
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI147870
Pays : United States

Investigateurs

Ashley L Babyak (AL)
Luis J Perez Valencia (LJ)
Shelly J Curran (SJ)
Mary E Richert (ME)
Willie J Young (WJ)
Sarah P Young (SP)
Billel Gasmi (B)
Michelly Sampaio De Melo (M)
Sabina Desar (S)
Saber Tadros (S)
Nadia Nasir (N)
Xueting Jin (X)
Sharika Rajan (S)
Esra Dikoglu (E)
Neval Ozkaya (N)
Grace Smith (G)
Elizabeth R Emanuel (ER)
Brian L Kelsall (BL)
Justin A Olivera (JA)
Megan Blawas (M)
Robert A Star (RA)
Nicole Hays (N)
Shreya Singireddy (S)
Jocelyn Wu (J)
Katherine Raja (K)
Ryan Curto (R)
Jean E Chung (JE)
Amy J Borth (AJ)
Kimberly A Bowers (KA)
Anne M Weichold (AM)
Paula A Minor (PA)
Mir Ahmad N Moshref (MAN)
Emily E Kelly (EE)
Mohammad M Sajadi (MM)
Thomas M Scalea (TM)
Douglas Tran (D)
Siamak Dahi (S)
Kristopher B Deatrick (KB)
Eric M Krause (EM)
Joseph A Herrold (JA)
Eric S Hochberg (ES)
Christopher R Cornachione (CR)
Andrea R Levine (AR)
Justin E Richards (JE)
John Elder (J)
Allen P Burke (AP)
Michael A Mazzeffi (MA)
Robert H Christenson (RH)
Zackary A Chancer (ZA)
Mustafa Abdulmahdi (M)
Sabrina Sopha (S)
Tyler Goldberg (T)
Yashvir Sangwan (Y)
Kristen Sudano (K)
Diane Blume (D)
Bethany Radin (B)
Madhat Arnouk (M)
James W Eagan (JW)
Robert Palermo (R)
Anthony D Harris (AD)
Thomas Pohida (T)
Marcial Garmendia-Cedillos (M)
George Dold (G)
Eric Saglio (E)
Phuoc Pham (P)

Informations de copyright

© 2022. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Bourgonje, A. R. et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. 251, 228–248 (2020).
doi: 10.1002/path.5471
Salamanna, F., Maglio, M., Landini, M. P. & Fini, M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front. Med. 7, 594495 (2021).
doi: 10.3389/fmed.2020.594495
Sridhar, S. & Nicholls, J. Pathophysiology of infection with SARS-CoV-2—what is known and what remains a mystery. Respirology 26, 652–665 (2021).
doi: 10.1111/resp.14091
Al-Aly, Z., Xie, Y. & Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259–264 (2021).
doi: 10.1038/s41586-021-03553-9
Crook, H., Raza, S., Nowell, J., Young, M. & Edison, P. Long covid-mechanisms, risk factors, and management. Brit. Med. J. 374, n1648 (2021).
doi: 10.1136/bmj.n1648
Puelles, V. G. et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 383, 590–592 (2020).
doi: 10.1056/NEJMc2011400
Martines, R. B. et al. Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States. Emerg. Infect. Dis. 26, 2005–2015 (2020).
doi: 10.3201/eid2609.202095
Bhatnagar, J. et al. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: an autopsy case series. J. Infect. Dis. 223, 752–764 (2021).
doi: 10.1093/infdis/jiab039
Dorward, D. A. et al. Tissue-specific immunopathology in fatal COVID-19. Am. J. Respir. Crit. Care Med. 203, 192–201 (2021).
doi: 10.1164/rccm.202008-3265OC
Schurink, B. et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe 1, e290–e299 (2020).
doi: 10.1016/S2666-5247(20)30144-0
Yao, X. H. et al. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 31, 836–846 (2021).
doi: 10.1038/s41422-021-00523-8
Remmelink, M. et al. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit. Care 24, 495 (2020).
doi: 10.1186/s13054-020-03218-5
Mukerji, S. S. & Solomon, I. H. What can we learn from brain autopsies in COVID-19. Neurosci. Lett. 742, 135528 (2021).
doi: 10.1016/j.neulet.2020.135528
Matschke, J. et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19, 919–929 (2020).
doi: 10.1016/S1474-4422(20)30308-2
Speranza, E. et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci. Transl. Med. 13, eabe8146 (2021).
doi: 10.1126/scitranslmed.abe8146
Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl Acad. Sci. USA 117, 7001–7003 (2020).
doi: 10.1073/pnas.2002589117
Vannella, K. M. et al. Evidence of SARS-CoV-2-specific T-cell-mediated myocarditis in a MIS-A case. Front. Imunol. 12, 779026 (2021).
doi: 10.3389/fimmu.2021.779026
Desai, N. et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat. Commun. 11, 6319 (2020).
doi: 10.1038/s41467-020-20139-7
Tonkin-Hill, G. et al. Patterns of within-host genetic diversity in SARS-CoV-2. Elife 10, e66857 (2021).
doi: 10.7554/eLife.66857
Lythgoe, K. A. et al. SARS-CoV-2 within-host diversity and transmission. Science 372, eabg0821 (2021).
doi: 10.1126/science.abg0821
Valesano, A. L. et al. Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts. PLoS Pathog. 17, e1009499 (2021).
doi: 10.1371/journal.ppat.1009499
Ko, S. H. et al. High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19. PLoS Pathog. 17, e1009431 (2021).
doi: 10.1371/journal.ppat.1009431
Brioschi, S. et al. Heterogeneity of meningeal B cells reveals a lymphopoietic niche at the CNS border. Science 373, eabf9277 (2021).
doi: 10.1126/science.abf9277
Wang, Y. et al. Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges. Immunity. 54, 2784–2794 (2021).
doi: 10.1016/j.immuni.2021.09.016
Song, E. et al. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep. Med. 2, 100288 (2021).
doi: 10.1016/j.xcrm.2021.100288
Jacobs, J. L. et al. SARS-CoV-2 viremia is associated with COVID-19 severity and predicts clinical outcomes. Clin. Infect. Dis. 10, ciab686 (2021).
Wong, L. R. & Perlman, S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses – are we our own worst enemy? Nat. Rev. Immunol. 22, 47–56 (2022).
doi: 10.1038/s41577-021-00656-2
Diamond, M. S. & Kanneganti, T. D. Innate immunity: the first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165–176 (2022).
doi: 10.1038/s41590-021-01091-0
Beyer, D. K. & Forero, A. Mechanisms of antiviral immune evasion of SARS-CoV-2. J. Mol. Biol. 434, 167265 (2022).
doi: 10.1016/j.jmb.2021.167265
Binnicker, M. J. Can testing predict SARS-CoV-2 infectivity? The potential for certain methods to be surrogates for replication-competent virus. J. Clin. Microbiol. 59, e0046921 (2021).
doi: 10.1128/JCM.00469-21
Alexandersen, S., Chamings, A. & Bhatta, T. R. SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication. Nat. Commun. 11, 6059 (2020).
doi: 10.1038/s41467-020-19883-7
van Kampen, J. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019. Nat. Commun. 12, 267 (2021).
doi: 10.1038/s41467-020-20568-4
Dimcheff, D. E. et al. Severe acute respiratory syndrome coronavirus 2 total and subgenomic RNA viral load in hospitalized patients. J. Infect. Dis. 224, 1287–1293 (2021).
doi: 10.1093/infdis/jiab215
Sidhu, M. S. et al. Defective measles virus in human subacute sclerosing panencephalitis brain. Virology 202, 631–641 (1994).
doi: 10.1006/viro.1994.1384
Huang, N. et al. SARS-CoV-2 infection of the oral cavity and saliva. Nat. Med. 27, 892–903 (2021).
doi: 10.1038/s41591-021-01296-8
Burbelo, P. D. et al. Sensitivity in detection of antibodies to nucleocapsid and spike proteins of severe acute respiratory syndrome coronavirus 2 in patients with coronavirus disease 2019. J. Infect. Dis. 222, 206–213 (2020).
doi: 10.1093/infdis/jiaa273
Burbelo, P. D., Goldman, R. & Mattson, T. L. A simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins. BMC Biotechnol. 5, 22 (2005).
doi: 10.1186/1472-6750-5-22
Wölfel, R. et al. Virological assessment of hospitalized patients with COVID-19. Nature 581, 465–469 (2020).
doi: 10.1038/s41586-020-2196-x
Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25, 2000045 (2020).
doi: 10.2807/1560-7917.ES.2020.25.3.2000045
Martin, M. Cutadapt removes adapter sequences from high-throughput sequence reads. EMBnet J. 17, 10–12 (2011).
doi: 10.14806/ej.17.1.200
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923
Carossino, M. et al. Detection of SARS-CoV-2 by RNAscope® in situ hybridization and immunohistochemistry techniques. Arch. Virol. 165, 2373–2377 (2020).
doi: 10.1007/s00705-020-04737-w
Williamson, B. N. et al. Clinical benefit of Remdesivir in rhesus macaques infected with SARS-CoV-2. Nature 585, 273–276 (2020).
doi: 10.1038/s41586-020-2423-5
Munster, V. J. et al. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature 585, 268–272 (2020).
doi: 10.1038/s41586-020-2324-7
Rosenke, K. et al. Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models. JCI Insight 5, e143174 (2020).
doi: 10.1172/jci.insight.143174

Auteurs

Sydney R Stein (SR)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Sabrina C Ramelli (SC)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

Alison Grazioli (A)

Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.

Joon-Yong Chung (JY)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Manmeet Singh (M)

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.

Claude Kwe Yinda (CK)

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.

Clayton W Winkler (CW)

Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.

Junfeng Sun (J)

Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

James M Dickey (JM)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Kris Ylaya (K)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Sung Hee Ko (SH)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Andrew P Platt (AP)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Peter D Burbelo (PD)

National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

Martha Quezado (M)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Stefania Pittaluga (S)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Madeleine Purcell (M)

University of Maryland School of Medicine, Baltimore, MD, USA.

Vincent J Munster (VJ)

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.

Frida Belinky (F)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Marcos J Ramos-Benitez (MJ)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD, USA.

Eli A Boritz (EA)

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Izabella A Lach (IA)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Daniel L Herr (DL)

R Adams Cowley Shock Trauma Center, Department of Medicine and Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.

Joseph Rabin (J)

R Adams Cowley Shock Trauma Center, Department of Surgery and Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA.

Kapil K Saharia (KK)

Department of Medicine, Division of Infectious Disease, University of Maryland School of Medicine, Baltimore, MD, USA.
Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.

Ronson J Madathil (RJ)

Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Ali Tabatabai (A)

Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.

Shahabuddin Soherwardi (S)

Hospitalist Department, TidalHealth Peninsula Regional, Salisbury, MD, USA.

Michael T McCurdy (MT)

Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Division of Critical Care Medicine, Department of Medicine, University of Maryland St. Joseph Medical Center, Towson, MD, USA.

Karin E Peterson (KE)

Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.

Jeffrey I Cohen (JI)

Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Emmie de Wit (E)

Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health, Hamilton, MT, USA.

Kevin M Vannella (KM)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Stephen M Hewitt (SM)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

David E Kleiner (DE)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Daniel S Chertow (DS)

Emerging Pathogens Section, Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA. chertowd@cc.nih.gov.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. chertowd@cc.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH